Scarica l'app Stockscreener
2.10
0.48%
0.01
Dopo l'orario di chiusura:
2.07
-0.03
-1.43%
Fractyl Health Inc Borsa (GUTS) Ultime notizie
Can Fractyl Health Inc. stock deliver surprise earnings beatJuly 2025 Snapshot & Low Drawdown Trading Techniques - ulpravda.ru
Is Fractyl Health Inc. stock a contrarian buyEarnings Miss & Risk Managed Investment Strategies - ulpravda.ru
Fractyl Health outlines strategic outlook for 2026 - MSN
Why retail investors favor Fractyl Health Inc. stockJuly 2025 Analyst Calls & Community Consensus Trade Alerts - ulpravda.ru
What margin trends mean for Fractyl Health Inc. stockLow Beta Stocks & Make Confident Moves With Forecasting Models - ulpravda.ru
Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness - The Globe and Mail
Fractyl Health, Inc. Announces Chief Financial Officer Changes - MarketScreener
Fractyl Health appoints Lara Smith Weber as new CFO By Investing.com - Investing.com South Africa
Fractyl Health Appoints New Chief Financial Officer - TipRanks
Fractyl Health appoints Lara Smith Weber as new CFO - Investing.com
Why a metabolic disease company is bringing in a new finance chief - Stock Titan
Fractyl Health announces catalyst-rich clinical and funding outlook - MSN
Fractyl Health: Advancing Revita and Rejuva Pipelines Toward 2026 Clinical and Regulatory Catalysts Supports Buy Rating - TipRanks
Fractyl Health Announces Catalyst-Rich Clinical and Funding Outlook - TipRanks
Millions stopping GLP-1 drugs face what's next as firm tests new option - Stock Titan
Fractyl Health’s REVEAL-1 study shows positive six-month results for Revita in maintaining weight and glycemic control post-GLP-1 use - MSN
Analysts Keep Buy Ratings on Fractyl Health (GUTS) - Finviz
Analysts keep buy ratings on Fractyl Health (GUTS) - MSN
Fractyl Health’s REVEAL-1 Study Shows Positive Six-Month Results for Revita in Maintaining Weight and Glycemic Control Post-GLP-1 Use - Yahoo Finance
More than 4,600 Massachusetts biotech workers lost jobs in 2025 as industry contracts - The Business Journals
Stop Loss: Why Fractyl Health Inc stock remains undervaluedWeekly Volume Report & Trade Opportunity Analysis - moha.gov.vn
Aug EndMonth: Why retail investors favor Fractyl Health Inc stock2025 Investor Takeaways & Low Volatility Stock Suggestions - moha.gov.vn
Entry Recap: Why Fractyl Health Inc stock remains resilientJuly 2025 Snapshot & AI Powered Market Entry Ideas - moha.gov.vn
GUTS SEC FilingsFractyl Health 10-K, 10-Q, 8-K Forms - Stock Titan
Is Fractyl Health Inc. stock in correction or buying zoneWeekly Market Report & Daily Stock Trend Watchlist - Улправда
Aug Technicals: Why Fractyl Health Inc stock remains undervaluedJuly 2025 Recap & Fast Moving Market Watchlists - moha.gov.vn
Canaccord Genuity reiterates Buy rating on Fractyl Health stock By Investing.com - Investing.com South Africa
Canaccord Genuity reiterates Buy rating on Fractyl Health stock - Investing.com
Why Fractyl Health Inc. stock remains resilient2025 Historical Comparison & Technical Entry and Exit Alerts - DonanımHaber
Why Fractyl Health Inc. stock is trending among retail tradersSwing Trade & Smart Money Movement Tracker - Улправда
Fractyl Health (GUTS) officer awarded 845,226 stock options at $2.24 - Stock Titan
Market Overview: Will Fractyl Health Inc. stock deliver shareholder value2025 Stock Rankings & Daily Profit Focused Stock Screening - Улправда
Will Fractyl Health Inc. stock deliver shareholder valueJuly 2025 Catalysts & Trade Opportunity Analysis Reports - Улправда
With 58% institutional ownership, Fractyl Health, Inc. (NASDAQ:GUTS) is a favorite amongst the big guns - Yahoo Finance
Fractyl Health (GUTS) officer receives 743,913 stock options at $2.24 - Stock Titan
Fractyl Health (GUTS) CEO receives 2,486,302 stock options grant - Stock Titan
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Fractyl Health Calls Tranche A Warrants - TipRanks
Fractyl Health Announces Call of Tranche A Warrants - TradingView — Track All Markets
Fractyl Health calls Tranche A warrants for exercise or cancellation By Investing.com - Investing.com Canada
Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones - The Manila Times
Fractyl Health (NASDAQ: GUTS) sets Dec. 30 deadline on Tranche A warrants - Stock Titan
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):